Related references
Note: Only part of the references are listed.Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study
I. Hafstroem et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Interpreting Registry-Derived Drug Studies: Does Societal Context Matter?
Joel M. Kremer et al.
ARTHRITIS AND RHEUMATISM (2009)
Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis
Shahin Jamal et al.
CLINICAL RHEUMATOLOGY (2009)
An Explanation for the Apparent Dissociation Between Clinical Remission and Continued Structural Deterioration in Rheumatoid Arthritis
A. K. Brown et al.
ARTHRITIS AND RHEUMATISM (2008)
The role of drug and disease registries in rheumatic disease epidemiology
Joel M. Kremer et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Paul Emery et al.
LANCET (2008)
Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
K. L. Hyrich et al.
RHEUMATOLOGY (2008)
Treatment response to a second or third TNF-inhibitor in RA:: results from the South Swedish Arthritis Treatment Group Register
J. A. Karisson et al.
RHEUMATOLOGY (2008)
Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study
Gerd R. Burmester et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis
D. van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2007)
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice
S. Bombardieri et al.
RHEUMATOLOGY (2007)
Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis - Results from a large UK national cohort study
Kimme L. Hyrich et al.
ARTHRITIS AND RHEUMATISM (2007)
Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Register
K. L. Hyrich et al.
RHEUMATOLOGY (2006)
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab - Results from the ASPIRE trial
JS Smolen et al.
ARTHRITIS AND RHEUMATISM (2006)
The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
FC Breedveld et al.
ARTHRITIS AND RHEUMATISM (2006)
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition
MC Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The benefit/risk profile of TNF-blocking agents: Findings of a consensus panel
MC Hochberg et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission
ETH Molenaar et al.
ARTHRITIS AND RHEUMATISM (2004)
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis - A randomized, controlled trial
EWS Clair et al.
ARTHRITIS AND RHEUMATISM (2004)
Prognostic factors for remission in early rheumatoid arthritis:: a multiparameter prospective study
L Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
T Möttönen et al.
ARTHRITIS AND RHEUMATISM (2002)